About Vaxart Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform.

Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and ...

Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and ...

Vaxart, Inc. begins trading today on OTCQX under the symbol “VXRT.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

About Vaxart, Inc. Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform.

Vaxart's (NASDAQ:VXRT) shares rose following the positive results from an early stage trial of its new oral pill vaccine for norovirus, a more advanced version compared to its first-generation ...

According to the latest study from BCC Research, "The Global Influenza Market" is expected to grow from $9.0 billion in 2024 to $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR ...

NIL News Powerful NIL gesture from Missouri star is transforming his hometown New Missouri star Damon Wilson II is using his NIL money to give back to his hometown.

ePHOTOzine brings you a daily round up of all the latest film and digital photography news including camera news, exhibitions, events, special offers, industry news, digital photography news ...